Haisco Pharmaceutical Group Co., Ltd.

¥58.86As of Sun 8 Nov 2026, 12:00 UTC
SZSE:002653Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR 14.24%
Div yield 0.89%
ROE 25.61%
Biotechnology
Beta (5Y) (0.08)
PE TTM 51.12
TSR TTM 5.25%
Mkt cap ¥65.29B
ROIC 24.05%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥64
9.10%
(56.41%)
Hold 3|0|1|4|3
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.61
0.68
0.72
0.74
12.61%
28.74%
34.48%
31.15%
Revenue¥B
2.768
2.850
2.847
2.895
2.28%
8.02%
7.50%
4.91%
Peers (US$9.787B)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
7.738
0.062
0.072
EBIT/Intx
0.799
2.193
1.543
Own earn%
(11.34)
(113.31)
(93.33)
Sh yield%
46.94
38.27
39.46
Owners
Insiders/Inst%
8.84
28.99
Short interest%
4.92
SBC / revenue%
2.73
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
5–17
$1 testx
—
Incr. ROIC%
9